Harvard Medical School (HMS) is accelerating the pace of therapeutic discovery and supporting initiatives aimed at solving some of humanity’s most acute biomedical challenges thanks to the landmark $200 million commitment from Len Blavatnik and the Blavatnik Family Foundation. The largest commitment in the School’s history, it is propelling HMS's mission to transform health through curiosity-driven research that stimulates the development of new therapies and tools to diagnose and prevent disease.
The Blavatnik Commitment to HMS supports four key areas:
The HMS Therapeutics Initiative, which is enhancing the impact of fundamental curiosity-driven research and catalyzing the development of new therapies.
Key Update: The HMS community was thrilled to have Len Blavatnik speak at the HMS Ideation Hub (I-Hub) and Translator Symposium on October 28, 2020.
Fertile intellectual communities that integrate data science and artificial intelligence capabilities and applications.
Key Update: Robert Gentleman was recently welcomed as founding executive director of the HMS Center for Computational Biomedicine.
A collaborative grants program that inspires cross-disciplinary research partnerships across the Harvard life sciences ecosystem.
Key Update: HMS is working to finalize agreements and looks forward to announcing the winners of the Blavatnik Therapeutics Challenge Awards.
|The Blavatnik Harvard Life Lab at Longwood, which will provide incubator space for early-stage, high-potential biotech startups.|
Featured Stewardship Report
Blavatnik Institute at Harvard Medical School
In recognition of this commitment, HMS named the Blavatnik Institute—an umbrella research institute that encompasses the School’s 11 basic and social science departments. Led by HMS Dean George Q. Daley, the Blavatnik Institute is home to world-class faculty working to solve the greatest problems of human health through fundamental and translational biomedical science research.